MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

19.89 6.19

Resumen

Variación precio

24h

Actual

Mínimo

18.6

Máximo

20.02

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

P/B

Media del Sector

48.528

87.826

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+0.48% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.26%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

13M

381M

Apertura anterior

13.7

Cierre anterior

19.89

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

183 / 361 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ene 2026, 19:05 UTC

Principales Movimientos del Mercado

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 ene 2026, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 ene 2026, 23:41 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 ene 2026, 23:33 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 ene 2026, 23:13 UTC

Adquisiciones, fusiones, absorciones

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 ene 2026, 23:10 UTC

Adquisiciones, fusiones, absorciones

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 ene 2026, 23:03 UTC

Charlas de Mercado

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 ene 2026, 21:50 UTC

Adquisiciones, fusiones, absorciones

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 ene 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 ene 2026, 21:15 UTC

Adquisiciones, fusiones, absorciones

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 ene 2026, 21:08 UTC

Adquisiciones, fusiones, absorciones

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 ene 2026, 20:39 UTC

Charlas de Mercado

Silver Settles at Another New High -- Market Talk

13 ene 2026, 20:21 UTC

Charlas de Mercado

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 ene 2026, 20:17 UTC

Charlas de Mercado

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 ene 2026, 19:08 UTC

Adquisiciones, fusiones, absorciones

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 ene 2026, 19:03 UTC

Ganancias

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 ene 2026, 18:50 UTC

Ganancias

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 ene 2026, 17:54 UTC

Charlas de Mercado

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 ene 2026, 17:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

13 ene 2026, 17:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 ene 2026, 17:49 UTC

Charlas de Mercado

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 ene 2026, 17:38 UTC

Charlas de Mercado

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

13 ene 2026, 17:19 UTC

Charlas de Mercado

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 ene 2026, 17:15 UTC

Charlas de Mercado

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

0.48% repunte

Estimación a 12 Meses

Media 19 USD  0.48%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

183 / 361 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat